Clinical Applications of Recombinant Human Bone Morphogenetic Protein and In Situ Tissue Engineering in Jaw Reconstruction
Clinical Applications of Recombinant Human Bone Morphogenetic Protein and In Situ Tissue Engineering in Jaw Reconstruction is organized by American Association of Oral and Maxillofacial Surgeons (AAOMS).
Original Release Date: November 8, 2016
Review Date: May 14, 2022
Expiration Date: May 14, 2025
Estimated time to complete this educational activity: 2.0 hours
Method of participation: Self-Study
Overview:
Recombinant Human Bone Morphogenetic Protein (rhBMP-2) regenerates normal bone de novo without the need and added morbidity of bone harvesting. Now ridge preservations, ridge augmentations, sinus lift surgeries and even continuity defects can be reconstructed in such grafting using tissue engineering directly in the patient, which is referred to as in situ tissue engineering.
Additional details will be posted as soon as information is available.
